Jack W. Lasersohn, Director at OncoMed Pharmaceuticals Inc (OMED), bought 13,140 shares at $14.74 ($192K) on 2015-09-28, disclosed to the SEC on 2015-09-30.
Open-market purchase of $192k OMED by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.74 | 10,000 | $147K | 76.8% |
| 2 | $14.15 | 3,140 | $44K | 23.2% |
| Total | $14.60 avg | 13,140 | $192K | 100% |
| Filing → |
| OMED | BUY | 2017-05-25 | $71K | — | Filing → |
| OMED | BUY | 2017-05-18 | $164K | — | Filing → |
| OMED | BUY | 2015-10-01 | $180K | — | Filing → |